New vaccine strategy could better protect cancer patients from dangerous infections
NCT ID NCT05417165
Summary
This study is testing whether giving pneumococcal vaccines more frequently provides better protection for people with chronic lymphocytic leukemia (CLL). The trial will compare the standard 5-year vaccination schedule against more frequent yearly vaccinations in 80 CLL patients who haven't received treatment yet. Researchers want to see if more frequent vaccinations help patients build stronger immune defenses against serious pneumococcal infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.